Advanced Therapies Europe / Agenda / Commercialisation of Next Generation Advanced Therapies

Sessions

CAR-T & Beyond: Future Cell Based Immunotherapeutic Strategies

Starting with the End in Mind: Translating Academic Research into Commercial Products

Innovative Technologies as a Driver of European CGT Commercialisation & Successful Market Adoption

Cross Country Collaboration for Development, Commercialisation and Access

The EU Health Technology Assessment Regulations: Pricing & Reimbursement Opportunities of Novel Therapeutics in Europe

A CGT Retrospective: Best Practice & Evidence Generation for Pricing, Reimbursement & Regulatory Approval

Disruptive Developments Digitalisation, AI and Virtualisation Supporting ATMP Progress

Back

CAR-T & Beyond: Future Cell Based Immunotherapeutic Strategies

07 Sep 2023

15:00

logo_footer

Company

Resources

Network

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

Phacilitate is a part of Clarion Events Limited. © Phacilitate 2022

This site uses cookies which are essential to make the site function effectively. By using our site you accept the terms of our cookie policy. Find out more.